Short Interest in China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Rises By 263.4%

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) was the recipient of a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 262,000 shares, an increase of 263.4% from the November 30th total of 72,100 shares. Based on an average daily volume of 880,400 shares, the days-to-cover ratio is currently 0.3 days. Currently, 7.6% of the shares of the stock are sold short.

China SXT Pharmaceuticals Stock Up 20.5 %

NASDAQ:SXTC traded up $0.08 during midday trading on Thursday, reaching $0.47. 6,681,333 shares of the stock traded hands, compared to its average volume of 838,115. China SXT Pharmaceuticals has a 12 month low of $0.30 and a 12 month high of $6.39. The company has a fifty day moving average of $0.46 and a 200 day moving average of $0.75. The company has a current ratio of 1.60, a quick ratio of 1.51 and a debt-to-equity ratio of 0.01.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.